Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease (Q77571421)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

Hormone Replacement Therapy

6 December 2019

main subject

1 reference

inferred from title

coronary artery disease

1 reference

M J van der Mooren

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

V Mijatovic

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

W M van Baal

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

C D Stehouwer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

27-36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

Menopause and heart disease. A review

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormone replacement and the menopause: a European position paper. Writing Group on Women's Health of the Fondazione Giovanni Lorenzini Medical Science Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Regression of Atherosclerosis in Female Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Estrogen replacement therapy after coronary angioplasty in women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Estrogen replacement therapy and prognosis after first myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effect of 17 beta-estradiol on plasma lipids and LDL oxidation in postmenopausal women with type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of post-menopausal oestrogen-progestogen replacement therapy on serum lipids and lipoproteins: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of transdermal 17 beta-oestradiol combined with oral progestogen on lipids and lipoproteins in hypercholesterolaemic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolaemia among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein Lp(a). A risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein(a) and Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein (a) and coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Changes in Lp(a) lipoprotein and lipid levels after cessation of female sex hormone production and estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormonal agents used in lowering lipoprotein(a).

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein (a) concentrations in postmenopausal women taking norethisterone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

A 2-year study on the beneficial effects of 17 beta-oestradiol-dydrogesterone therapy on serum lipoproteins and Lp(a) in postmenopausal women: no additional unfavourable effects of dydrogesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of hormone replacement therapy on lipoprotein(a) and lipids in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormonal regulation of lipoprotein(a) levels: effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Lipoprotein (a). Heterogeneity and biological relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Binding and degradation of lipoprotein(a) and LDL by primary cultures of human hepatocytes. Comparison with cultured human monocyte-macrophages and fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Triglyceride-rich lipoprotein interactions with Lp(a)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Plasma homocysteine and cardiovascular disease mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Homocyst(e)ine and arterial occlusive diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Biological chemistry of thiols in the vasculature and in vascular-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Plasma homocysteine and menopausal status.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Postmenopausal oral 17beta-estradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

A randomized controlled study of the effects of 17beta-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Vitamins and progression of atherosclerosis in hyper-homocyst(e)inaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Folate and Vitamin B 6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Exercise echocardiography in postmenopausal hormone users with mild systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Differing Responses in Blood Pressure Over 24 Hours in Normotensive Women Receiving Oral or Transdermal Estrogen Replacement Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Cardiovascular protection by oestrogen--a calcium antagonist effect?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5122%2898%2900056-5

7 January 2021

10.1016/S0378-5122(98)00056-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9819780%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference